KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molina Healthcare (MOH) Common Equity (2016 - 2025)

Historic Common Equity for Molina Healthcare (MOH) over the last 17 years, with Q4 2025 value amounting to $4.1 billion.

  • Molina Healthcare's Common Equity fell 949.73% to $4.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.1 billion, marking a year-over-year decrease of 949.73%. This contributed to the annual value of $4.1 billion for FY2025, which is 949.73% down from last year.
  • As of Q4 2025, Molina Healthcare's Common Equity stood at $4.1 billion, which was down 949.73% from $4.2 billion recorded in Q3 2025.
  • In the past 5 years, Molina Healthcare's Common Equity registered a high of $4.8 billion during Q2 2024, and its lowest value of $2.2 billion during Q1 2021.
  • Its 5-year average for Common Equity is $3.6 billion, with a median of $3.8 billion in 2023.
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 4220.65% in 2023, then plummeted by 1213.84% in 2025.
  • Molina Healthcare's Common Equity (Quarter) stood at $2.6 billion in 2021, then grew by 12.7% to $3.0 billion in 2022, then soared by 42.21% to $4.2 billion in 2023, then increased by 6.67% to $4.5 billion in 2024, then dropped by 9.5% to $4.1 billion in 2025.
  • Its Common Equity was $4.1 billion in Q4 2025, compared to $4.2 billion in Q3 2025 and $4.6 billion in Q2 2025.